Cargando…
Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
BACKGROUND: Dysregulation of chromatin regulators (CRs) can perturb the tumor immune microenvironment, but the underlying mechanism remains unclear. We focused on uterine corpus endometrial carcinoma (UCEC) and used gene expression data from TCGA-UCEC to investigate this mechanism. METHODS: We used...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022674/ https://www.ncbi.nlm.nih.gov/pubmed/36936912 http://dx.doi.org/10.3389/fimmu.2023.1139126 |
_version_ | 1784908771891347456 |
---|---|
author | Wu, Qihui Tian, Ruotong Liu, Jiaxin Ou, Chunlin Li, Yimin Fu, Xiaodan |
author_facet | Wu, Qihui Tian, Ruotong Liu, Jiaxin Ou, Chunlin Li, Yimin Fu, Xiaodan |
author_sort | Wu, Qihui |
collection | PubMed |
description | BACKGROUND: Dysregulation of chromatin regulators (CRs) can perturb the tumor immune microenvironment, but the underlying mechanism remains unclear. We focused on uterine corpus endometrial carcinoma (UCEC) and used gene expression data from TCGA-UCEC to investigate this mechanism. METHODS: We used weighted gene co-expression network analysis (WGCNA) and consensus clustering algorithm to classify UCEC patients into Cluster_L and Cluster_H. TME-associated CRs were identified using WGCNA and differential gene expression analysis. A CR risk score (CRRS) was constructed using univariate Cox and LASSO-Cox regression analyses. A nomogram was developed based on CRRS and clinicopathologic factors to predict patients' prognosis. RESULTS: Lower CRRS was associated with lower grade, more benign molecular subtypes, and improved survival. Patients with low CRRS showed abundant immune infiltration, a higher mutation burden, fewer CNVs, and better response to immunotherapy. Moreover, low CRRS patients were more sensitive to 24 chemotherapeutic agents. CONCLUSION: A comprehensive assessment of CRRS could identify immune activation and improve the efficacy of UCEC treatments. |
format | Online Article Text |
id | pubmed-10022674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100226742023-03-18 Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma Wu, Qihui Tian, Ruotong Liu, Jiaxin Ou, Chunlin Li, Yimin Fu, Xiaodan Front Immunol Immunology BACKGROUND: Dysregulation of chromatin regulators (CRs) can perturb the tumor immune microenvironment, but the underlying mechanism remains unclear. We focused on uterine corpus endometrial carcinoma (UCEC) and used gene expression data from TCGA-UCEC to investigate this mechanism. METHODS: We used weighted gene co-expression network analysis (WGCNA) and consensus clustering algorithm to classify UCEC patients into Cluster_L and Cluster_H. TME-associated CRs were identified using WGCNA and differential gene expression analysis. A CR risk score (CRRS) was constructed using univariate Cox and LASSO-Cox regression analyses. A nomogram was developed based on CRRS and clinicopathologic factors to predict patients' prognosis. RESULTS: Lower CRRS was associated with lower grade, more benign molecular subtypes, and improved survival. Patients with low CRRS showed abundant immune infiltration, a higher mutation burden, fewer CNVs, and better response to immunotherapy. Moreover, low CRRS patients were more sensitive to 24 chemotherapeutic agents. CONCLUSION: A comprehensive assessment of CRRS could identify immune activation and improve the efficacy of UCEC treatments. Frontiers Media S.A. 2023-03-03 /pmc/articles/PMC10022674/ /pubmed/36936912 http://dx.doi.org/10.3389/fimmu.2023.1139126 Text en Copyright © 2023 Wu, Tian, Liu, Ou, Li and Fu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wu, Qihui Tian, Ruotong Liu, Jiaxin Ou, Chunlin Li, Yimin Fu, Xiaodan Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
title | Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
title_full | Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
title_fullStr | Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
title_full_unstemmed | Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
title_short | Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
title_sort | deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022674/ https://www.ncbi.nlm.nih.gov/pubmed/36936912 http://dx.doi.org/10.3389/fimmu.2023.1139126 |
work_keys_str_mv | AT wuqihui decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma AT tianruotong decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma AT liujiaxin decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma AT ouchunlin decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma AT liyimin decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma AT fuxiaodan decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma |